Biopharmaceuticals

San Carlos, Calif. & Redwood City, Calif., August 10, 2026 BeOne Medicines Ltd. and Revolution Medicines, Inc. announced a...

Barcelona, Spain, August 9, 2026 Almirall announced a collaboration and licensing agreement with CrystalO, a China-based biotechnology company, to...

Boston, MA, August 9, 2026 Asimov announced the successful completion of a cell line development campaign in collaboration with...

Sophia Antipolis, France, August 10, 2026 Nicox SA announced that its exclusive Chinese licensee Ocumension Therapeutics has submitted a...

MARSEILLE, France, August 10, 2026 Innate Pharma SA announced plans to initiate the TELLOMAK-3 confirmatory Phase 3 study of...

CAMBRIDGE, Mass., August 7, 2026 Scholar Rock announced that the U.S. Food and Drug Administration (FDA) review of its...

BETHESDA, Md., August 6, 2026 Northwest Biotherapeutics announced that it has entered into a non-binding Memorandum of Understanding (MOU)...

MELBOURNE, Australia, August 6, 2026 Propanc Biopharma announced compelling preclinical and early translational findings for its lead investigational therapy...

Palo Alto, California, August 6, 2026 Kodiak Sciences Inc. has completed enrollment of the first pivotal 300-patient cohort in...

Daejeon, South Korea, August 5, 2026 Alteogen Inc. has entered into an exclusive license agreement with an undisclosed global...